Skip to main content

pharmacology Archives

Probing epilepsy’s molecular sparks

May. 10, 2012—Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.

Read more


Minds wide open: Neuroscience at Vanderbilt

Apr. 6, 2012—Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.

Read more


Mouse model for autism yields clues to a 50-year-old mystery

Mar. 20, 2012—A genetic variation that causes early disruptions in serotonin signaling in the brain may contribute to autism spectrum disorder and other enduring effects on behavior.

Read more


Vanderbilt expanding research enterprise into Williamson County

Mar. 9, 2012—With the addition of a new 18,000-square-foot laboratory to be located within the Cool Springs Life Sciences Center, Vanderbilt University is expanding its research enterprise into Williamson County.

Read more


Combo combats dizziness

Mar. 9, 2012—Some patients may need a combo of medications to combat a condition that causes dizziness.

Read more


VU researcher has personal motive for investigating malaria

Feb. 3, 2012—Vanderbilt researcher and Gabon, Africa, native is working to discover ways to kill malaria-spreading mosquitoes.

Read more


Pumping up the pancreas in pregnancy

Jan. 20, 2012—A strain of mutant mice provide a novel model for studying glucose intolerance and gestational diabetes during pregnancy and suggest that certain molecules may be useful for therapeutic applications.

Read more


Vanderbilt sets record for number of new AAAS fellows

Dec. 14, 2011—Fourteen Vanderbilt researchers have been elected fellows of the American Association for the Advancement of Science (AAAS).

Read more


Move out, cholesterol

Dec. 8, 2011—Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis.

Read more


Drug target for deadly heart infection

Dec. 1, 2011—Structural biology studies of a bacterial protein suggest a new target for treating life-threatening heart infection.

Read more


Vanderbilt doctors to screen patients taking statins for genetic risk factors

Oct. 28, 2011—Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.

Read more


Information flow reduced in psychosis

Oct. 21, 2011—Bipolar depression and schizophrenia share patterns of changes in neurons that regulate information flow, new research shows.

Read more


Upcoming Events

22 November
10:00 AM

29 November
10:00 AM

06 December
10:00 AM

13 December
10:00 AM

MORE EVENTS »